Conexiant’s news site is now MDSpire News. Learn more
Advertisement
May long COVID improve without full recovery?
Investigators found that symptom improvement remained possible years after infection, but patients with multisystem symptoms had lower likelihood of improvement.
Clinical Scorecard: May long COVID improve without full recovery?
At a Glance
Category
Detail
Condition
Long COVID symptom improvement and resolution over time
Key Mechanisms
The study tracked changes in Long COVID Research Index (LCRI) scores; it did not investigate biological mechanisms.
Target Population
Adults in the RECOVER-Adult cohort who met criteria for likely long COVID 12, 18, or 24 months after their first COVID-19 infection.
Care Setting
Prospective observational research conducted at 83 sites across the United States; the article does not specify a clinical care setting.
Key Highlights
Among adults with likely long COVID at 12 months, the estimated probability of sustained improvement was 36% by 24 months and 50% by 36 months.
Complete symptom resolution was estimated in 15% by 24 months and 27% by 36 months.
By 36 months, adjusted improvement probabilities ranged from 60% for predominantly smell or taste disturbances to 19% for multisystem symptoms.
Improvement probabilities were similar for female and male participants; estimates differed by age and infection period.
The observational design cannot establish causes of improvement, and the primary outcome represented improvement below the likely long COVID threshold, not complete recovery.
Guideline-Based Recommendations
Diagnosis
The study defined likely long COVID as an LCRI score of at least 11.
Management
The study did not evaluate treatments received during follow-up and provides no treatment recommendations.
Monitoring & Follow-up
Participants completed symptom assessments at 3-month intervals.
Sustained improvement was defined as an LCRI score below 11 at two consecutive visits.
Risks
Participants were selected for likely long COVID at specific time points, limiting generalizability to all people with a history of COVID-19.
Symptom-based classification could not establish whether all reported symptoms were attributable to infection.
Missing follow-up assessments required statistical imputation, and the observational design precluded causal conclusions.
Patient & Prescribing Data
The primary analysis included 1,019 adults with likely long COVID 12 months after first infection; additional analyses included participants meeting criteria at 18 or 24 months.
Treatments during follow-up were not evaluated. The authors called for placebo-controlled therapeutic intervention trials.
Clinical Best Practices
Interpret the reported improvement estimates as cohort-level observational findings, not individual prognoses.
Distinguish sustained improvement below the LCRI threshold from complete symptom resolution.
Do not infer that age, infection period, or symptom subtype caused differences in improvement.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
